Eligibility
Applicant type, geography, program rules and required conditions.
My Organization Fit Score
See how strongly this opportunity fits your organization.
Atlas combines public grant intelligence with the details of your organization to evaluate eligibility, strategic alignment, funding potential, timing, project fit and submission burden.
GrantSouth Dakota Richard Hagen-Minerva Harvey Scholarship 2027
Atlas Opportunity Score40/100
FundingAnnual minimum awards: $1,000 for each of the first two years, $1,500 for the third year, and $2,500 for the fourth year; number of scholarships determined by the Hagen-Harvey Scholarship Board.
DeadlineFebruary 28, 2027. Electronic applications must be received by 5:00 PM CST; mailed applications must be postmarked by the deadline.
Required next actionEligible students should complete the 2026-2027 application, assemble required transcripts, two recommendation letters, tribal-enrollment verification, ACT/ACCUPLACER score, and personal essay, then submit electronically to Melissa.Bothun@state.sd.us or mail to SD DOE by the deadline. No N9+, QC Healthcare, or Dr. Miltie applicant outreach is indicated.
Current statusActiveSource verificationSeptember 14, 2026
Tell Atlas Who You Are
Request your organization-specific analysis.
The form will carry the grant context with it, so you only need to provide the details Atlas cannot know from the opportunity itself.
How Atlas Scores Fit
Useful enough to guide action, structured enough to scale.
Strategic Alignment
How directly the organization's goals and use case match the funder's priorities.
Funding Potential
Available dollars, allowable uses, match burden and the amount that can realistically support the project.
Actionability
Deadline, documentation burden, readiness and the practical work required to submit a strong application.
A High Score Is the Beginning
When the fit is strong, Atlas shows you why.
The goal is not to hand you another number. It is to identify the opportunities worth your attention and make the next step obvious.